Treatment of Cardiovascular Risk Factors in Women

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|22|31|3580-3596

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.31, 2015-10, pp. : 3580-3596

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Assessment of cardiovascular risk and simultaneous treatment of multiple risk factors is important in patients with metabolic syndrome

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 24, Iss. 9, 2008-09 ,pp. : 13-17

Adis International

Access to resources Recommend Favorite

Effects of the Thiazolidinediones on Cardiovascular Risk Factors

By Gilling L.   Suwattee P.   DeSouza C.   Asnani S.   Fonseca V.  

American Journal of Cardiovascular Drugs, Vol. 2, Iss. 3, 2002-01 ,pp. : 149-156

Adis International

Access to resources Recommend Favorite

Smoking, Haemostatic Factors, and Cardiovascular Risk

By  

Current Pharmaceutical Design, Vol. 13, Iss. 16, 2007-06 ,pp. : 1661-1667

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial [ Hot Topic: Modifying Cardiovascular Risk Factors: Novel Cardiovascular Targets for Treatment by Noninvasive Imaging Techniques (Executive Editors: Aurelio Leone and Luigi Landini) ]

By  

Current Pharmaceutical Design, Vol. 14, Iss. 18, 2008-06 ,pp. : 1743-1744

Bentham Science Publishers

Access to resources Recommend Favorite

Pioglitazone and Rosiglitazone: Effects of Treatment with a Thiazolidinedione on Lipids and Non Conventional Cardiovascular Risk Factors

By  

Current Clinical Pharmacology, Vol. 3, Iss. 2, 2008-05 ,pp. : 77-84

Bentham Science Publishers

Access to resources Recommend Favorite